20/20 BioResponse

6 articles about 20/20 BioResponse

• 20/20 Launching First COVID-19 Rapid Antibody Test Authorized by FDA for Point-of-Care Use

  10/7/2020

  20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits. These kits were the first to receive an emergency use authorization (EUA) from the FDA for point-of-care (POC) use with fingerstick blood samples on Sep

• 20/20 BioResponse Confirms Accuracy of Rapid Coronavirus Test Kits in Hospitals in Several U.S. States

  4/3/2020

  Rapid Antibody Test Generates Results in under 10 minutes from Blood Drop without Laboratory Equipment

• 20/20 BioResponse to Launch Rapid Coronavirus Test Kits in U.S. following “Green Light” from FDA

  3/19/2020

  Rapid Antibody Test Generates Results in under 15 minutes from Blood Drop without Laboratory Equipment or Personnel

• Minnesota Medtech Week 2015: Seven Co-Located Expos Cover All Corners Of The Advanced Design And Manufacturing Industry

  10/22/2015

• 20/20 BioResponseTest Kits Demonstrated Effective for Detecting Ricin by Leading Government Lab

  5/2/2013

• 20/20 BioResponse's BioCheck® Kit for Screening Suspicious Powders Receives SAFETY Act Designation from DHS

  10/18/2007